ArticleClinical and translational discovery2022

Higher BCG-induced trained immunity prevalence predicts protection from COVID-19: Implications for ongoing BCG trials.

Samer Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.